Evolus, Inc. (EOLS)

USD 9.48

(0.69%)

Operating Expenses Summary of Evolus, Inc.

  • Evolus, Inc.'s latest annual operating expenses in 2023 was 189.75 Million USD , up 14.1% from previous year.
  • Evolus, Inc.'s latest quarterly operating expenses in 2024 Q1 was 47.2 Million USD , up 3.88% from previous quarter.
  • Evolus, Inc. reported a annual operating expenses of 150.3 Million USD in annual operating expenses 2022, up 25.51% from previous year.
  • Evolus, Inc. reported a annual operating expenses of 119.75 Million USD in annual operating expenses 2021, up 11.98% from previous year.
  • Evolus, Inc. reported a quarterly operating expenses of 52.5 Million USD for 2024 Q2, up 11.23% from previous quarter.
  • Evolus, Inc. reported a quarterly operating expenses of 45.43 Million USD for 2023 Q4, down -5.39% from previous quarter.

Annual Operating Expenses Chart of Evolus, Inc. (2023 - 2015)

Historical Annual Operating Expenses of Evolus, Inc. (2023 - 2015)

Year Operating Expenses Operating Expenses Growth
2023 189.75 Million USD 14.1%
2022 150.3 Million USD 25.51%
2021 119.75 Million USD 11.98%
2020 106.93 Million USD -12.13%
2019 121.69 Million USD 241.45%
2018 35.64 Million USD 203.96%
2017 11.72 Million USD -41.27%
2016 19.96 Million USD -35.55%
2015 30.98 Million USD 0.0%

Peer Operating Expenses Comparison of Evolus, Inc.

Name Operating Expenses Operating Expenses Difference
Bright Green Corporation 8.25 Million USD -2199.309%
Alpha Teknova, Inc. 45.85 Million USD -313.788%
ANI Pharmaceuticals, Inc. 195.98 Million USD 3.176%
Aquestive Therapeutics, Inc. 44.85 Million USD -323.059%
Collegium Pharmaceutical, Inc. 159.2 Million USD -19.189%
Cosmos Health Inc. 26.18 Million USD -624.803%
Journey Medical Corporation 54.59 Million USD -247.582%
Embecta Corp. 528.4 Million USD 64.088%
Esperion Therapeutics, Inc. 271.89 Million USD 30.209%
Dynavax Technologies Corporation 219.14 Million USD 13.409%
Intra-Cellular Therapies, Inc. 590 Million USD 67.838%
Pacira BioSciences, Inc. 326.37 Million USD 41.859%
PainReform Ltd. 9.58 Million USD -1879.956%
Sunshine Biopharma, Inc. 13.12 Million USD -1345.841%
Sunshine Biopharma, Inc. 13.12 Million USD -1345.841%
SCYNEXIS, Inc. 51.84 Million USD -265.991%
Safety Shot Inc 12.1 Million USD -1467.001%
China SXT Pharmaceuticals, Inc. 3.06 Million USD -6082.71%
Procaps Group, S.A. 199.47 Million USD 4.872%
Theratechnologies Inc. 72.75 Million USD -160.816%
Harrow Health, Inc. 89.97 Million USD -110.907%
Sonoma Pharmaceuticals, Inc. 9.44 Million USD -1908.882%
Biofrontera Inc. 39.95 Million USD -374.884%
DURECT Corporation 43.71 Million USD -334.082%
Supernus Pharmaceuticals, Inc. 529.01 Million USD 64.129%
Cronos Group Inc. 96.7 Million USD -96.216%
OptiNose, Inc. 85.1 Million USD -122.978%
Ironwood Pharmaceuticals, Inc. 232.12 Million USD 18.251%
Kala Pharmaceuticals, Inc. 39.15 Million USD -384.66%
RedHill Biopharma Ltd. -9.56 Million USD 2084.719%
Organogenesis Holdings Inc. 314.13 Million USD 39.593%
Guardion Health Sciences, Inc. 9.73 Million USD -1850.08%
Cumberland Pharmaceuticals Inc. 43.04 Million USD -340.884%
Radius Health, Inc. 265.92 Million USD 28.643%
Universe Pharmaceuticals INC 13.84 Million USD -1270.902%
ProPhase Labs, Inc. 37.85 Million USD -401.318%
Phibro Animal Health Corporation 260.29 Million USD 27.099%
Procaps Group S.A. 187.24 Million USD -1.343%
Alvotech 285.43 Million USD 33.52%
TherapeuticsMD, Inc. 9.82 Million USD -1831.389%
Viatris Inc. 5.96 Billion USD 96.819%
Rockwell Medical, Inc. 15.37 Million USD -1134.285%
Aytu BioPharma, Inc. 59.84 Million USD -217.111%
SIGA Technologies, Inc. 22.04 Million USD -760.857%
Tilray Brands, Inc. 251.35 Million USD 24.506%
Lifecore Biomedical, Inc. 49.03 Million USD -286.963%
Shineco, Inc. 17.94 Million USD -957.269%
PetIQ, Inc. 192.72 Million USD 1.539%
Regencell Bioscience Holdings Limited 3.99 Million USD -4654.509%
Incannex Healthcare Limited 30.05 Million USD -531.415%
Neurocrine Biosciences, Inc. 1.59 Billion USD 88.114%
Alimera Sciences, Inc. 62.64 Million USD -202.931%
Silver Spike Investment Corp. 762.49 Thousand USD -24786.687%
Assertio Holdings, Inc. 368.58 Million USD 48.517%
Shuttle Pharmaceuticals Holdings, Inc. 5.88 Million USD -3124.139%
Petros Pharmaceuticals, Inc. 17.8 Million USD -965.551%
Clever Leaves Holdings Inc. 21.16 Million USD -796.4%
Cyclo Therapeutics, Inc. 21.04 Million USD -801.807%
Avadel Pharmaceuticals plc 164.96 Million USD -15.029%
Hempacco Co., Inc. 7.59 Million USD -2397.996%
Talphera, Inc. 11.99 Million USD -1482.116%
Alvotech 285.43 Million USD 33.52%
Eagle Pharmaceuticals, Inc. 140.71 Million USD -34.854%
Lantheus Holdings, Inc. 344.9 Million USD 44.982%
Currenc Group, Inc. 24 Million USD -690.594%
Kamada Ltd. 45.42 Million USD -317.732%
Indivior PLC 911 Million USD 79.17%
Evoke Pharma, Inc. 12.4 Million USD -1429.125%
Flora Growth Corp. 10.57 Million USD -1693.733%
Cyclo Therapeutics, Inc. 21.04 Million USD -801.807%
HUTCHMED (China) Limited 436.23 Million USD 56.5%
Amphastar Pharmaceuticals, Inc. 154.13 Million USD -23.113%
Akanda Corp. 3.48 Million USD -5347.354%